Optura Raises $17.5M in Series A Funding Led by Salesforce Ventures

The company plans to use the funding to enhance its AI capabilities, expand its platform development teams, and strengthen partnerships in large language modelling (LLM).

The investment follows a strong seed round and reflects the growing shift in healthcare AI from experimentation to real business results. Optura helps organizations evaluate the value and impact of AI, prioritise investments, and track real-time business performance and returns from AI initiatives.

Since launching last year, Optura has gained strong adoption among enterprise healthcare organizations, including Independence Blue Cross, Prime Therapeutics, and Ardent Health. The platform now supports more than $2 billion in AI initiatives, with $120 million in tracked value, a reported 700% return on AI investments, and over 250 identified use cases.

"The question for health plans is no longer whether to invest in AI; it's whether those investments are actually delivering better outcomes for members," said Michael R. Vennera, Executive Vice President, and Chief Strategy, Technology, and Operations Officer, Independence Blue Cross. "Optura answers that question for an organization like IBX, where every decision connects back to the people we serve, that kind of accountability, and visibility isn't optional; its how we ensure AI creates real value where it matters most."

"Optura is solving one of our industry's biggest challenges: helping healthcare organizations structure and capture real value from AI programs," said Kurt Sheline, Partner, Echo Health Ventures. "Its platform delivers the combination of data insights, tools and technology that we believe are consequential for moving into the next phase of AI transformation – accountability and orchestrated systems that deliver long-term value across the entire enterprise."

Read More:Graphon AI Raises $8.3M in Seed Funding

"Healthcare organizations are under growing pressure to move beyond AI experimentation and deliver measurable business outcomes," said Katie Thiry, Managing Director, Salesforce Ventures. "Optura is helping customers bring greater rigor and visibility to AI investment decisions – identifying high-value use cases, measuring impact and accelerating time to ROI. As enterprises look for more disciplined approaches to AI adoption, we believe Optura is well-positioned to help lead that shift."

"The hundreds of AI use cases coupled with the introduction of foundational models into healthcare markets, like Claude for Healthcare, are driving AI spend and increasing risk," said Andy Fanning, Co-Founder and CEO of Optura. "It has also created a never-ending menu of point solutions, without an objective framework to help healthcare leaders measure the ROI on their AI investment decisions. We developed Optura to take out that guesswork and help healthcare organizations objectively measure results."

About Optura

Founded in 2024 by Andy Fanning and Michael Hollis, Optura is a healthcare AI platform focused on measuring Return on AI Investment (ROAI™). The platform helps healthcare organisations identify where AI can create the most value, simulate expected returns before deployment, and track real time performance after implementation. By turning existing workflows and operating procedures into AI driven solutions, Optura helps healthcare leaders make more informed AI investment decisions and avoid low-value pilot projects.

Read More:Synthetic Raises $10M in Seed Funding Led by Khosla Ventures